Concord Biotech Ltd Quarterly Result
Concord Biotech Ltd
NSE: CONCORDBIO
Net Profit - Last Quarter
Concord Biotech Ltd Quarterly Results Key Highlights
- The revenue of Concord Biotech Ltd for the Dec '25 is ₹ 287.74 crore as compare to the Sep '25 revenue of ₹ 262.7 crore.
- This represent the growth of 9.53% The ebitda of Concord Biotech Ltd for the Dec '25 is ₹ 104.98 crore as compare to the Sep '25 ebitda of ₹ 104.13 crore.
- This represent the growth of 0.82% The net profit of Concord Biotech Ltd for the Dec '25 is ₹ 63.64 crore as compare to the Sep '25 net profit of ₹ 63.06 crore.
- This represent the growth of 0.92%.
Concord Biotech Ltd Quarterly Results Analysis
Market Price of Concord Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 11 May 2026 | 1198.85 |
| 08 May 2026 | 1175.15 |
| 07 May 2026 | 1197.15 |
| 06 May 2026 | 1223.05 |
| 05 May 2026 | 1184.65 |
| 04 May 2026 | 1195.1 |
| 30 Apr 2026 | 1140.15 |
| 29 Apr 2026 | 1131.9 |
| 28 Apr 2026 | 1071.05 |
| 27 Apr 2026 | 1057.45 |
Historical Revenue of Concord Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Concord Biotech Ltd
Historical EBITDA of Concord Biotech Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Concord Biotech Ltd
Historical Net Profit of Concord Biotech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Concord Biotech Ltd
Concord Biotech Ltd News Hub
Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter
Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against
Read more
09 Aug 24
Volumes jump at Concord Biotech Ltd counter
K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst
Read more
29 Aug 24
Concord Biotech to announce Quarterly Result
Concord Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2025. Powered
Read more
24 May 25
Concord Biotech to conduct board meeting
Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow
Read more
06 Nov 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
Credit Report 2024
Concalls
Popular Search
About Concord Biotech Ltd
- Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
- Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
- Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.
FAQs for Quarterly Results of Concord Biotech Ltd
What key financial metrics are included in Concord Biotech Ltd's quarterly results?
When does Concord Biotech Ltd announce its quarterly results?
How does Concord Biotech Ltd's quarterly performance impact its stock price?
What is the impact of Concord Biotech Ltd's quarterly results on dividends?
Are there any special announcements usually made during Concord Biotech Ltd's quarterly results?
